Concord Medical Services Holdings Limited (CCM) is a publicly traded company in the Healthcare — Medical - Care Facilities industry listed on NYSE. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.
Analysis Summary
Concord Medical Services Holdings Limited reported revenue of $460.5M in the most recent fiscal year, growing at a 5-year CAGR of 15.6%.
Balance sheet quality for CCM: current ratio of 0.5, net debt of $3.34B. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Price
| Price | $3.92 |
| Market Cap | $1M |
| Exchange | NYSE |
| Country | CN |
What to look at in Healthcare / Pharma
The R&D pipeline is the invisible asset. Patents expiring = revenues evaporating. Look at innovation and cash flow.
- R&D / Revenue — Shows investment in future pipeline. Serious pharma reinvests 15-20%
- 5y EPS growth — After patent expirations, are they still growing?
- Gross margin — Branded pharma >70%. Generics much lower — defines the business type
- FCF / Net Income — Earnings quality — big pharma should convert >90%
- ROIC — Capital reinvested efficiently — key in pharma due to long R&D cycles
- Net debt / EBITDA — Pharma acquisitions pile up debt — watch the post-M&A picture
- P/E vs own 10y history — The best comparison is with its own history, not with peers
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| CCM | Concord Medical Services Holdings Limited | ||||
| 0J1R.L | HCA Healthcare, Inc. | $97.6B | 14.35 | -112.9% | |
| HCA | HCA Healthcare, Inc. | $93.2B | 14.32 | -112.9% | |
| 0RPS.L | Medicover AB (publ) | $32.4B | 36.30 | 5.74 | 16.0% |
| THC | Tenet Healthcare Corporation | $21.4B | 10.05 | 4.71 | |
| 0I7E.L | DaVita Inc. | $13.3B | |||
| DVA | DaVita Inc. | $12.4B | 16.71 | ||
| FMS | Fresenius Medical Care AG & Co. KGaA | $12.3B | 12.31 | 0.87 | 7.2% |
Price Performance
| 1 month | -14.22% |
| 3 months | -26.32% |
| Year-to-date | +1.55% |
| 1 year | -30.62% |
| 3 years | -69.85% |
| 5 years | -87.15% |
52-Week Range
| 52-week High | $6.98 |
| 52-week Low | $3.18 |
| Avg Volume (90d) | 61K |
Dividend History
| Date | Amount | Yield |
|---|---|---|
| 2015-12-23 | $0.9900 | 101.02% |
| 2014-08-05 | $0.9000 | 91.84% |
| 2014-01-16 | $0.7100 | 72.45% |
| 2014-01-16 | $0.7200 | 73.47% |
| 2011-08-29 | $0.1800 | 18.37% |
Related companies: ADTX · BACK · CELU · HEPA · IVF · PTPI · SISI
Explore sector: Healthcare · Medical - Care Facilities
More sections of CCM: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks